Delivery Order SPE2DB22D3016-SPE2DB24FAKM3
Award Date 1/25/24
Potential Completion Date 1/26/24
Potential Value $8.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,264.79 order is for the supply of Lidocaine 5% Patches to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lidocaine 5% Patches. The $1,954.88 award has a completion date of May 17, 2022. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that the company holds with DLA. The IDC, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,952.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4564110488 - Lidocaine 5% Patch 30S, and has a period of performance through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of...
- This is a $4,355.30 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Lidocaine 5% Patches. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of 4,564,097,616 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,604.39 firm fixed price delivery order has a completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of lidocaine 5% patches. The order, valued at $10,864.32, has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract, valued at $1,464.96, is to provide Lidocaine 5% Patches to the Defense Logistics Agency (DLA) Troop Support Medical, which supports the U.S. Department of Defense. Amerisourcebergen Drug Corporation is the prime contractor and there is no set-aside designation. Amerisourcebergen Drug...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a $1,139.60 firm fixed price delivery order contract from the Defense Logistics Agency (DLA) to provide Lidocaine 5% Patch 30s. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, was awarded a $16,096.21 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide 4563603815 Lidocaine 5% Patch 30s. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through December 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $42,385.93 firm fixed price delivery order is for the supply of 4,564,054,872 units of Lidocaine 5% Patch 30s, a medical product, with a period of performance through March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAKM3Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract with a potential value of $8,230.27 by the Defense Logistics Agency (DLA) to provide Lidocaine 5% patches. This order is not designated under any set-aside program. Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to support Department of Defense military treatment programs and facilities worldwide.
Generated 4/25/24, 7:23 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 1/25/24 |